FDA dispute panel says no to Cardima
This article was originally published in Clinica
Executive Summary
Delivering a blow to Cardima, the US FDA's medical device dispute resolution panel (MDDRP) has recommended against approving the company's minimally-invasive microcatheter system for treating atrial fibrillation (AF).